ARCHIVES

New Drug Approvals Point To Greater Role Of Randomization In Cancer Clinical Trials. European Standards Will Demand More Rigor.

This article is from The Cancer Letter archive.

Vol. 32 No. 07 | February 24, 2006

Download PDF Visit The Full Archive

Related Articles

MOPP Consequences, Including Increase In cure Rate, Describe By DeVita

May 25, 1979

Broder To Leave In March; Sondik To Be Acting Director

January 27, 1995

Breast Cancer Action Plan Committee Outrages By Plans for $14M In NCI Funds

August 1, 1997

Three Win Medals Of Science For Biology; Social Worker, Survivor, Wins.

February 11, 2000

New ESA Label Maintains 12 g/dL

November 9, 2007

DCT Board Approves Major Clinical Trials Changes, Regional Groups, New Effort In Surgical Oncology

October 10, 1980